Shkreli Called Before Congress To Talk Drug Price Hike
Martin Shkreli, the ex-pharmaceutical executive who was recently indicted on securities fraud charges, has received a subpoena to testify before Congress about his former company's decision to hike the price of...To view the full article, register now.
Already a subscriber? Click here to view full article